Biosensors International Group, Ltd. is a medical device company that specializes in developing, manufacturing and licensing technologies for use in interventional cardiology procedures and critical care.

The global headquarters of the company is located in Singapore and holds the main manufacturing facilities and research and development centers.

The Swiss office is also the legal manufacturer of BioMatrix, the company's current leading product.

Biosensors International also licenses its proprietary drug-eluting stent technologies to other medical device companies and specialty stent providers, including Terumo, Devax, Inc., and Xtent, Inc. Biosensors International Group has a joint-venture in Hong Kong listed as Shandong Weigao to market and distribute coronary stents in China.

This article about a medical, pharmaceutical or biotechnological corporation or company is a stub.